AlphaMoats
Health Care

HALOZYME THERAPEUTICS INC HALO

$110.40
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1329 by number of owners
% of all portfolios
0.00%
Rank #1293 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.6%
of Torray's portfolio

Live price

Compare with the quarter-end price of $110.40 reported in the 13F

Superinvestors holding HALO

Recent activity
Torray · Torray Investment Partners
0.6%
▼ Reduce-0.4%$4.3M